Gelonghui, December 13|Nanxin Pharmaceutical (688189.SH) said on the investor interactive platform that the company's drugs for influenza prevention include Liwei (paramivir sodium chloride injection) and Nanxin (oseltamivir phosphate dry suspension). Among them, Liwei (paramivir sodium chloride injection) can be used for all age groups, and Nanxin (oseltamivir phosphate dry suspension) can be used to prevent influenza A and B in people aged 1 year and above. Common symptoms of diseases caused by influenza, syncytial infection, and mycoplasma infections include fever and sore throat. The company's product Baoshite (compound ibuprofen tablets) can be used to treat symptoms of fever caused by upper respiratory tract infections and pain caused by otorhinopharyngeal inflammation. Currently, the company is making every effort to promote and accelerate the research and development of the Paramivir inhalation solution project, and is striving to be approved for listing as soon as possible, so as to play a good role in fighting the influenza virus.